IMAG

EDUCATION

Workshop

TAKING ADVANTAGE OF MULTIMODALITY IMAGING IN DAILY CLINICAL PRACTICE

Co-Chair(s)

• Karima A.

  Karima Addetia, MD

  Assistant Professor
• Gillian N.

  Gillian Nesbitt, MD FRCPC FACC FASE

  Director of Echocardiography Sinai Health System
  University of Toronto

Presenter(s)

• Kalie K.

  Kalie Kebed, MD

  Cardiology Fellow
• 

  Matthias Friedrich

  Professor of Medicine
  McGill University Health Centre

Imaging modalities are very often complementary to one another. Echocardiography is usually first-line in the evaluation of cardiac symptomatology. With the increasing use of cardiovascular MRI, it has become obvious that cardiovascular MRI can have additive value over echocardiography with the potential to improve the diagnostic and decision-making potential of imaging in a number of individual patient scenarios. The purpose of this workshop is to highlight 2 of the areas in which cardiovascular MRI and echocardiography can play complementary roles namely myocarditis and cardiac amyloidosis. In some cases, computed tomography, PET and other modalities can also play a part in clinical decision-making in these diseases. This session is especially important to the audience as Canada works to improve access to all of these modalities in urban centers.

Co-chair: Karima Addetia, Gillian Nesbitt

(10 + 5 min)
Echocardiography in Myocarditis – Kalie Kebed

(10 + 5 min)
Beyond Echocardiography in Myocarditis - Mathias Friedrich

(10 + 5 min)
Echocardiography Cardiac Amyloid – Gillian Nesbitt

(10 + 5 min)
Beyond Echocardiography in Cardiac Amyloid – Karima Addetia

Each topic is presented as a 10 min lecture with 5 min for chair-directed questions.

Target Audience(s):

Trainee (clinical)
General: All cardiovascular (clinical and research) health professionals
Clinical cardiologists

Learning Objectives

At the conclusion of this session, participants will be able to:

• diagnose and decide on the appropriate management strategy for cardiac amyloidosis with the help of multimodality imaging;
• better assess patients with myocarditis using multimodality imaging; and
• recognize findings on cardiac MRI pertaining to both cardiac amyloid and myocarditis.